Overexpression of thrombospondin-1 in stromal myofibroblasts is associated with tumor growth and nodal metastasis in gastric carcinoma

Journal of Surgical Oncology

Volumn 106, Issue 1, 2012, Pages 94-100

  Lin, Xian Dong ^a   Chen, Shu Qin ^a   Qi, Yuan Lin ^a   Zhu, Jin Wei ^a   Tang, Yang ^a   Lin, Jian Yin ^a  

^a FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Gastric carcinoma; Myofibroblast; Nodal metastasis; Thrombospondin 1

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CD34 ANTIGEN; MESSENGER RNA; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; CELL DIFFERENTIATION; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MYOFIBROBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CARCINOMA; STROMA CELL; TUMOR GROWTH; TUMOR VOLUME; VALIDATION STUDY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MYOFIBROBLASTS; NEOPLASM STAGING; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH; STOMACH NEOPLASMS; THROMBOSPONDIN 1; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 84862786502     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23037     Document Type: Article

References (40)

1. Hamilton SRAL: Tumor of the digestic system. In: World Health Organization Classification of tumors. In "Pathology, Genetics." Lyon: IARC; 2000. 39.
2. Tung-Ping Poon R, Fan ST, Wong J: Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 2000;232:10-24.
3. Chen H, Herndon ME, Lawler J: The cell biology of thrombospondin-1. Matrix Biol 2000;19:597-614.
4. Baenziger NL, Brodie GN, Majerus PW: A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sci USA 1971;68:240-243.
5. Streit M, Velasco P, Brown LF, et al.: Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas. Am J Pathol 1999;155:441-452. (Pubitemid 29370394)
6. Fontanini G, Boldrini L, Calcinai A, et al.: Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density. Clin Cancer Res 1999;5:155-161. (Pubitemid 29045189)
7. Grossfeld GD, Ginsberg DA, Stein JP, et al.: Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis, and tumor progression. J Natl Cancer Inst 1997;89:219-227. (Pubitemid 27073759)
8. Kazerounian S, Yee KO, Lawler J: Thrombospondins in cancer. Cell Mol Life Sci 2008;65:700-712.
9. Kasper HU, Ebert M, Malfertheiner P, et al.: Expression of thrombospondin-1 in pancreatic carcinoma: Correlation with microvessel density. Virchows Arch 2001;438:116-120. (Pubitemid 32186578)
10. Wang TN, Albo D, Tuszynski GP: Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery 2002;132:220-225. (Pubitemid 35024765)
11. Yee KO, Connolly CM, Duquette M, et al.: The effect of thrombospondin-1 on breast cancer metastasis. Breast Cancer Res Treat 2009;114:85-96.
12. Zhang J, Ito R, Oue N, et al.: Expression of thrombospondin-1 is correlated with microvessel density in gastric carcinoma. Virchows Arch 2003;442:563-568. (Pubitemid 36819250)
13. Albo D, Shinohara T, Tuszynski GP: Up-regulation of matrix metalloproteinase 9 by thrombospondin 1 in gastric cancer. J Surg Res 2002;108:51-60. (Pubitemid 35373815)
14. Lauren P: The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965;64:31-49.
15. Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001;29:e45.
16. Yuan JS, Reed A, Chen F, Stewart CN, Jr: Statistical analysis of real-time PCR data. BMC Bioinformatics 2006;7:85.
17. Kellermann MG, Sobral LM, da Silva SD, et al.: Mutual paracrine effects of oral squamous cell carcinoma cells and normal oral fibroblasts: Induction of fibroblast to myofibroblast transdifferentiation and modulation of tumor cell proliferation. Oral Oncol 2008;44:509-517. (Pubitemid 351608623)
18. Spaeth EL, Dembinski JL, Sasser AK, et al.: Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009;4:e4992.
19. De Falco E, Porcelli D, Torella AR, et al.: SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 2004;104:3472-3482. (Pubitemid 39564415)
20. Lee YJ, Koch M, Karl D, et al.: Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1. Cancer Res 2010;70:948-956.
21. Chauhan H, Abraham A, Phillips JR, et al.: There is more than one kind of myofibroblast: Analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 2003;56:271-276. (Pubitemid 36459796)
22. De Wever O, Mareel M: Role of tissue stroma in cancer cell invasion. J Pathol 2003;200:429-447. (Pubitemid 36818244)
23. De Wever O, Demetter P, Mareel M, et al.: Stromal myofibroblasts are drivers of invasive cancer growth. Int J Cancer 2008;123:2229-2238.
24. Petersen OW, Lind Neilsen H, Gudjonsson T, et al.: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001;3:213-217. (Pubitemid 32631699)
25. Kalluri R, Zeisberg M: Fibroblasts in cancer. Nat Rev Cancer 2006;6:392-401.
26. Nagasawa T: Microenvironmental niches in the bone marrow required for B-cell development. Nat Rev Immunol 2006;6:107-116.
27. Schultz-Cherry S, Murphy-Ullrich JE: Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J Cell Biol 1993;122:923-932. (Pubitemid 23241101)
28. Tada H, Isogai S: The fibronectin production is increased by thrombospondin via activation of TGF-beta in cultured human mesangial cells. Nephron 1998;79:38-43. (Pubitemid 28204036)
29. Schultz-Cherry S, Ribeiro S, Gentry L, Murphy-Ullrich JE: Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J Biol Chem 1994;269:26775-26782. (Pubitemid 24332871)
30. Daniel C, Schaub K, Amann K, et al.: Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Diabetes 2007;56:2982-2989. (Pubitemid 350223633)
31. Zhou Y, Poczatek MH, Berecek KH, et al.: Thrombospondin 1 mediates angiotensin II induction of TGF-beta activation by cardiac and renal cells under both high and low glucose conditions. Biochem Biophys Res Commun 2006;339:633-641. (Pubitemid 41739714)
32. Fitchev PP, Wcislak SM, Lee C, et al.: Thrombospondin-1 regulates the normal prostate in vivo through angiogenesis and TGF-beta activation. Lab Invest 2010;90:1078-1090.
33. Bhowmick NA, Neilson EG, Moses HL: Stromal fibroblasts in cancer initiation and progression. Nature 2004;432:332-337. (Pubitemid 39551661)
34. Worthley DL, Giraud AS, Wang TC: Stromal fibroblasts in digestive cancer. Cancer Microenviron 2010;3:117-125.
35. Eyden B: The myofibroblast: Phenotypic characterization as a prerequisite to understanding its functions in translational medicine. J Cell Mol Med 2008;12:22-37.
36. Ishii G, Sangai T, Oda T, et al.: Bone-marrow-derived myofibroblasts contribute to the cancer-induced stromal reaction. Biochem Biophys Res Commun 2003;309:232-240. (Pubitemid 37006422)
37. Karnoub AE, Dash AB, Vo AP, et al.: Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007;449:557-563. (Pubitemid 47525152)
38. Miura S, Kodaira S, Hosoda Y: Immunohistologic analysis of the extracellular matrix components of the fibrous stroma of human colon cancer. J Surg Oncol 1993;53:36-42. (Pubitemid 23133884)
39. Ronnov-Jessen L, Petersen OW, Koteliansky VE, et al.: The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells. J Clin Invest 1995;95:859-873.
40. Neaud V, Faouzi S, Guirouilh J, et al.: Human hepatic myofibroblasts increase invasiveness of hepatocellular carcinoma cells: Evidence for a role of hepatocyte growth factor. Hepatology 1997;26:1458-1466. (Pubitemid 27520010)